[Medication control monitoring in amiodarone therapy. What is essential?].
作者信息
Füessl H S, Stiefelhagen P
出版信息
MMW Fortschr Med. 2014 May 15;156(9):17.
PMID:24908872
Abstract
摘要
相似文献
1
[Medication control monitoring in amiodarone therapy. What is essential?].
MMW Fortschr Med. 2014 May 15;156(9):17.
2
[Treatment with amiodarone].[使用胺碘酮进行治疗]
Ugeskr Laeger. 2015 Jun 8;177(24):1168-71.
3
Intravenous amiodarone.静脉注射胺碘酮。
Med Lett Drugs Ther. 1995 Dec 8;37(963):114-5.
4
[Treatment with amiodarone].[使用胺碘酮治疗]
Ugeskr Laeger. 2014 Jun 2;176(23).
5
Amiodarone pulmonary toxicity.胺碘酮肺毒性。
Clin Chest Med. 2004 Mar;25(1):65-75. doi: 10.1016/S0272-5231(03)00144-8.
6
[Amiodarone-induced thyroid gland dysfunctions].胺碘酮所致甲状腺功能障碍
Dtsch Med Wochenschr. 2010 Apr;135(16):807-11. doi: 10.1055/s-0030-1251935. Epub 2010 Apr 13.
7
Amiodarone hepatotoxicity.胺碘酮肝毒性。
Curr Vasc Pharmacol. 2008 Jul;6(3):228-36. doi: 10.2174/157016108784912019.
8
Clinical utility and adverse effects of amiodarone therapy.
AACN Adv Crit Care. 2010 Oct-Dec;21(4):333-8; quiz 339-40. doi: 10.1097/NCI.0b013e3181ef86fe.
9
[Follow-up of patients treated by amiodarone].[胺碘酮治疗患者的随访]
Rev Med Liege. 1998 Dec;53(12):762-5.
10
Monitoring the use of amiodarone: compliance with guidelines.监测胺碘酮的使用：对指南的遵循情况
Intern Med J. 2006 May;36(5):289-93. doi: 10.1111/j.1445-5994.2006.01068.x.
Zotero 插件